November 12, 2022, the 2022 BioPacific Conference and 23rd Annual Conference of CABS was held in San Mateo, California, USA. The conference topic was ‘Resilience and Ingenuity, Embracing Opportunities in a New Normal’, which attracted more than 600 attendees globally from the life science and biopharmaceutical industry. As the conference partner, Aton Biotech showcased their integrated CDMO service platform at booth 52.
During the conference, Aton Biotech held many discussions with attendees and organizations at Aton Biotech’s booth, presented the industry-leading end-to-end biopharmaceutical CDMO solution to many customers and partners from all over the world.
In addition, Mr. Min Park, Chief Business Officer of Aton Biotech, attended the conference and delivered a presentation entitled "Accelerate Molecule to Market", sharing Aton Biotech's platform strategy of accelerating partner pipeline to market leveraging extensive experience in various stages of products from pre-clinical to commercialization. The presentation was highly recognized by many biopharmaceutical companies, R&D institutions, and industry with high affirmation.
Looking forward, Aton Biotech will continue to focus on enabling innovation from concept to market with quality and speed for our global partners, and fully leverage on our experienced integrated biopharmaceutical platforms, global GMP standard system and rich project experience to drive partner success.